Compass Therapeutics (CMPX) Short Interest Ratio & Short Volume → AI to Meet the Same Fate as EVs? (From Porter & Company) (Ad) Free CMPX Stock Alerts $1.98 -0.07 (-3.41%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Compass Therapeutics Short Interest DataCurrent Short Volume1,880,000 sharesPrevious Short Volume1,840,000 sharesChange Vs. Previous Month+2.17%Dollar Volume Sold Short$4.31 millionShort Interest Ratio / Days to Cover3.6Last Record DateMarch 15, 2024Outstanding Shares137,590,000 sharesFloat Size82,140,000 sharesShort Percent of Float2.29%Today's Trading Volume176,553 sharesAverage Trading Volume504,062 sharesToday's Volume Vs. Average35% Short Selling Compass Therapeutics ? Sign up to receive the latest short interest report for Compass Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCMPX Short Interest Over TimeCMPX Days to Cover Over TimeCMPX Percentage of Float Shorted Over Time Ad Porter & CompanyAI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. Compass Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20241,880,000 shares $4.31 million +2.2%2.3%3.6 $2.29 2/29/20241,840,000 shares $3.28 million -6.6%2.4%3.5 $1.78 2/15/20241,970,000 shares $3.47 million -9.6%2.6%3.6 $1.76 1/31/20242,180,000 shares $2.83 million +10.1%2.8%4.1 $1.30 1/15/20241,980,000 shares $3.58 million -12.8%2.6%3.9 $1.81 12/31/20232,270,000 shares $3.54 million +8.1%2.8%4.4 $1.56 Get the Latest News and Ratings for CMPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Compass Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20232,100,000 shares $3.34 million -21.4%2.6%5.9 $1.59 11/30/20232,670,000 shares $4.41 million -10.1%3.3%8.5 $1.65 11/15/20232,970,000 shares $4.40 million +4.2%3.6%10.8 $1.48 10/31/20232,850,000 shares $5.13 million -12.8%3.5%13 $1.80 10/15/20233,270,000 shares $6.25 million -23.2%4.0%13.5 $1.91 9/30/20234,260,000 shares $8.39 million -5.1%5.2%16.5 $1.97 9/15/20234,490,000 shares $9.56 million +1.4%5.5%14.6 $2.13 8/31/20234,430,000 shares $10.32 million -1.1%5.5%8.4 $2.33 8/15/20234,480,000 shares $11.07 million -2.4%5.5%8.1 $2.47 7/31/20234,590,000 shares $13.17 million -1.3%6.0%8 $2.87 7/15/20234,650,000 shares $13.35 million +8.4%6.1%8.1 $2.87 6/30/20234,290,000 shares $13.64 million +93.2%5.9%7.4 $3.18 6/15/20232,220,000 shares $7.28 million +8.8%3.3%3.9 $3.28 5/31/20232,040,000 shares $5.92 million -1.0%3.0%5.9 $2.90 5/15/20232,060,000 shares $6.84 million -5.9%3.1%5.9 $3.32 4/30/20232,190,000 shares $6.59 million +5.3%3.3%6 $3.01 4/15/20232,080,000 shares $6.45 million +4.5%3.1%4.8 $3.10 3/31/20231,990,000 shares $6.51 million -6.6%3.0%4.7 $3.27 3/15/20232,130,000 shares $7.58 million +17.7%3.2%5.7 $3.56 2/28/20231,810,000 shares $6.86 million -18.1%2.7%4.9 $3.79 2/15/20232,210,000 shares $8.80 million +16.3%3.2%6.5 $3.98 1/31/20231,900,000 shares $7.60 million +84.5%2.5%6.2 $4.00 1/15/20231,030,000 shares $5.35 million +10.2%1.4%4.5 $5.19 12/30/2022935,000 shares $4.70 million +197.3%1.2%5.4 $5.03 12/15/2022314,500 shares $1.41 million +112.6%0.4%1.8 $4.49 11/30/2022147,900 shares $607,869.00 +36.2%0.2%0.8 $4.11 11/15/2022108,600 shares $515,850.00 -17.1%0.2%0.6 $4.75 10/31/2022131,000 shares $413,960.00 -21.9%0.2%0.7 $3.16 10/15/2022167,800 shares $523,536.00 -13.2%0.3%1 $3.12 9/30/2022193,400 shares $440,952.00 +271.2%0.4%1.1 $2.28 9/15/202252,100 shares $162,552.00 +143.5%0.1%0.3 $3.12 8/31/202221,400 shares $58,850.00 -41.4%0.0%0.2 $2.75 8/15/202236,500 shares $105,850.00 -22.3%0.1%0.3 $2.90 7/31/202247,000 shares $122,200.00 -36.1%0.1%0.3 $2.60AI to Meet the Same Fate as EVs? (Ad)When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. CMPX Short Interest - Frequently Asked Questions What is Compass Therapeutics' current short interest? Short interest is the volume of Compass Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 1,880,000 shares of CMPX short. 2.29% of Compass Therapeutics' shares are currently sold short. Learn More on Compass Therapeutics' current short interest. What is a good short interest ratio for Compass Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMPX shares currently have a short interest ratio of 4.0. Learn More on Compass Therapeutics's short interest ratio. What is a good short interest percentage for Compass Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.29% of Compass Therapeutics' floating shares are currently sold short. Is Compass Therapeutics' short interest increasing or decreasing? Compass Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,880,000 shares, an increase of 2.2% from the previous total of 1,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Compass Therapeutics' float size? Compass Therapeutics currently has issued a total of 137,590,000 shares. Some of Compass Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Compass Therapeutics currently has a public float of 82,140,000 shares. How does Compass Therapeutics' short interest compare to its competitors? 2.29% of Compass Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Compass Therapeutics: Scilex Holding (6.82%), Gritstone bio, Inc. (9.86%), Sutro Biopharma, Inc. (3.72%), Century Therapeutics, Inc. (7.57%), Third Coast Bancshares, Inc. (0.55%), Coherus BioSciences, Inc. (22.99%), X4 Pharmaceuticals, Inc. (8.47%), Elevation Oncology, Inc. (11.63%), Cardiff Oncology, Inc. (6.29%), Black Diamond Therapeutics, Inc. (3.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Compass Therapeutics stock? Short selling CMPX is an investing strategy that aims to generate trading profit from Compass Therapeutics as its price is falling. CMPX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Compass Therapeutics? A short squeeze for Compass Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMPX, which in turn drives the price of the stock up even further. How often is Compass Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMPX, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Scilex Short Interest Gritstone bio Short Interest Sutro Biopharma Short Interest Century Therapeutics Short Interest Third Coast Bancshares Short Interest Coherus BioSciences Short Interest X4 Pharmaceuticals Short Interest Elevation Oncology Short Interest Cardiff Oncology Short Interest Black Diamond Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMPX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research